ORIC Pharmaceuticals Inc (ORIC)
9.03
+0.31
(+3.56%)
USD |
NASDAQ |
Apr 23, 11:33
ORIC Pharmaceuticals Net Income (TTM): -100.70M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -100.70M |
| September 30, 2023 | -93.21M |
| June 30, 2023 | -92.56M |
| March 31, 2023 | -89.91M |
| December 31, 2022 | -89.12M |
| September 30, 2022 | -91.05M |
| June 30, 2022 | -84.64M |
| March 31, 2022 | -85.36M |
| December 31, 2021 | -78.72M |
| Date | Value |
|---|---|
| September 30, 2021 | -84.20M |
| June 30, 2021 | -91.32M |
| March 31, 2021 | -81.34M |
| December 31, 2020 | -73.70M |
| September 30, 2020 | -53.80M |
| June 30, 2020 | -34.80M |
| March 31, 2020 | -29.74M |
| December 31, 2019 | -26.88M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-100.70M
Minimum
Dec 2023
-26.88M
Maximum
Dec 2019
-75.36M
Average
-84.64M
Median
Jun 2022
Net Income (TTM) Benchmarks
| Geron Corp | -184.13M |
| Verastem Inc | -87.37M |
| Karyopharm Therapeutics Inc | -143.10M |
| Syndax Pharmaceuticals Inc | -209.36M |
| Arvinas Inc | -367.30M |